levels, 145 mmol/L). Other electrolyte imbalances included hypernatremia, hypophosphatemia, and hypermagnesemia. Creatinine kinase was moderately raised (maximum 1,497 IU/L) with myoglobinemia, suggesting rhabdomyolysis, and he developed moderate renal failure (maximum creatinine, 269 mmol/L). His urine output in the first 24 h on the PICU was 0.4 mL/kg/h.
Fluid was increased by 10%, but further rises in sodium levels and worsening renal function were noted. It was decided that dehydration was the key factor driving the hypercalcemia. Dehydration at presentation was reestimated at 10%. Fluid was changed to 4% dextrose with 0.18% saline and recalculated at maintenance plus 7.5% correction over 48 h. A furosemide infusion was commenced to maintain a urine output of 3-4 mL/kg/h. Adjunct intravenous hydrocortisone was added. Renal ultrasonography (day 2) excluded nephrocalcinosis. Bisphosphonate therapy was considered, but it was felt this would not address the underlying problems and was not without risk given the renal function.
The boy's blood glucose levels stabilized by day 3 (,10 mol/L). Hypercalcemia, renal function, and hypernatremia normalized within a week. His serum calcium concentration 9 days after initial presentation was 2.46 mmol/L. He made a full recovery with no neurologic deficit.
DKA as a cause of severe hypercalcemia has not previously been described. Hypercalcemia in DKA is likely secondary to severe metabolic acidosis and insulin deficiency (2) . Other DKA-related factors are IGF-1 deficiency (3) and hyperglycemia (4). Potential factors in our case also include hypophosphatemia, rhabdomyolysis with acute renal failure (5), and immobilization.
Management proved challenging, recognizing both the need for adequate fluid replacement to treat the hypercalcemia, and also the need for fluid restriction to manage the cerebral edema.
In conclusion, hypercalcemia in DKA requires prompt identification and treatment to avoid life-threatening complications. We recommend that calcium levels are checked routinely in all patients with DKA. 
